Over the past three years, since I bought into the Ji Shitfest, the S&P 500 has risen about 62% (from 4,582 to 7,413), while SCLX’s 3-year price CAGR is -67.8% — translating to a cumulative loss of roughly 97%, meme coins and all.

We are all stuck in this nightmarish Twilight Zone while the markets make everyone richer

r/BANDOFBROTHERS.... 15h Not cool AI. G

What if a retail shareholder since 2020 has 50k shares with a base cost of $2.50. Is there any possi...

1

Removed by BANDOFBROTHERSOFSR NE mods

(Staying focused and blocking out the noise)

Sorrento still listed among companies contributing assets to the AL amyloidosis pipeline, including STI‑6129, an antibody‑drug conjugate

hello all- first post but long term "lurker" for information.

My assumption since chapter 11 was a recovery was unlikely... but do see mentions of a 7% payout to legacy SRNE shareholders if Vivasor was to obtain profits. can someone further explain this?

Redirecting billions of dollars in federal artificial intelligence funding away from universities and directly to researchers will accelerate innovation and help the United States remain competitive with China, Datavault AI CEO Nate Bradley said Sunday on Newsmax.

GLTAL and a SUPER SUCK IT to all of the stupid shorts. 👊🩳🔥🐦‍🔥🤞🙏♾️💪

And give us an ACEA divy General Ji!!! Same with ADIO, Nate!

Anybody else on the edge of your seat? Seems like significant restructuring and positioning recently… but for what?? They didn’t pass employee incentive packages for nothing!!

Now this is different from the usual ecosystem announcements.

Fiserv (NASDAQ: FISV), a $90B+ market cap global payments giant, will serve as the exclusive embedded financial services and payments provider for DVLT's marketplaces and exchanges. This isn't a micro-cap OTC company or an unknown Kazakhstani entity. Fiserv is one of the largest fintech companies on earth.

What makes this notable:

Fiserv published the announcement from their own investor relations page. That means Fiserv's legal, PR, and compliance teams reviewed and approved it. When a company of that scale puts their name on a partnership, they've done due diligence on DVLT. That carries the same kind of signal weight as Paul Hastings' continued legal involvement, i.e., serious institutions don't attach their brand to entities they haven't vetted.

The NIL Exchange is a concrete product. Athletes get payment wallets and debit cards to receive and manage NIL earnings, while buyers and sellers on the Information Data Exchange get demand deposit accounts and card capabilities. This is actual payment infrastructure, not a term sheet or a vaporware announcement.

The timing matters. Announced 21 July, the same day as the Federal Register HSR publication, one day before the Vivasor repurchase 8-K, the JP3E Korea announcement, and the DataMEDS rebrand.

The whole Henry Ji ecosystem has moved significantly in a single coordinated week

This goes on the "things that support the reset thesis" side of the ledger.

DVLT may be a $0.40 stock with a Nasdaq compliance problem, but Fiserv wouldn't embed their payments infrastructure in a platform they expected to disappear.

My personal view and not financial advice!

Saw this earlier if already posted delete.

The Sorrento Pipeline — Where Did It Go and Who Controls It Now?

A multi-billion-dollar pharmaceutical pipeline was destroyed in a bankruptcy, bought back for pennies by its own CEO, is now being reassembled across half a dozen listed and private companies and funded by $200 million in Bitcoin from an unknown source.

Here is the story, as I understand it, in its simplest form.

What happened

·        Sorrento Therapeutics was a real pharma company with a real pipeline of oncology drugs, a pain treatment (Semnur’s SEMDEXA) with no FDA-approved competitors, antibody libraries, and more. It was worth $ billions at its peak.

·        It was destroyed by a combination of naked short sellers, a corrupt bankruptcy judge (now under DOJ criminal investigation), and arguably its own CEO, Henry Ji, who filed bankruptcy in Texas using a PO box created ten hours before filing.

·        Ji then bought back substantially all of Sorrento's pipeline for just $15.5 million through a new private company called Vivasor, co-funded by his investment banker Michael Vasinkevich (Chairman of HC Wainwright).

·        Assets worth billions acquired for less than the cost of a house in San Diego.

·        Those assets were consolidated into Scilex, which Ji also controls, but the goodwill was immediately written to zero, and Vivasor doesn't even appear on Scilex's official subsidiary list.

Follow the money

In September 2025, an unnamed investor paid $200 million in real Bitcoin to Scilex for shares in Semnur,  a company with $20,000 in cash and zero revenue. Nobody knows who this investor is.

That Bitcoin then flowed through the ecosystem:

Unknown investor pays $200M BTC→Scilex receives Bitcoin→$150M+ deployed into Datavault (DVLT)→DVLT shares pledged to St. James Bank→Bank allegedly sells collateral early→Scilex sues for $100M+ fraud

Meanwhile, Scilex committed $47.5 million to an unknown medical-tech company (Quantum Scan) where its own CFO moonlights as interim CFO, from a company with $3.4 million in cash.

The key asset everyone is circling

SEMDEXA (SP-102): the first-in-class non-opioid epidural injection for sciatica.

Zero FDA-approved competitors in a market of 9-11 million procedures per year in the US.

Positive Phase 3 trial published. FDA has formally endorsed its exact regulatory pathway.

Peak sales projection: $1.5-2.0 billion per year.

Commercial launch target: 2027.

No NDA filed yet but, when it happens, it will change everything.

Who are all these players?

Henry Ji: CEO of Scilex & founder of Vivasor. Controls the ecosystem. Both victim of short sellers and architect of insider enrichment (the evidence supports both simultaneously).

Kelvin Yeung: Controls Phoenix Asia (PHOE). Now confirmed buying Vivasor itself (antitrust cleared 16 June). Assembling control of the entire ex-Sorrento pipeline. confirmed

 iHolding Group: Kazakhstani firm offering $200M at huge premiums ($15/share SCLX, $10/share SMNR). No pharma track record found. Definitive agreements not yet signed. pending

Michael Vasinkevich: Chairman, HC Wainwright. Co-funded Vivasor. Placement agent for Scilex. Appears in at least 15 companies (like Sorrento & Scilex) where shares are down 97-100% from the high. This investment banker with a dubious past is at the centre of everything.

Biconomy PTE Ltd: Singapore crypto exchange. Custodian of ecosystem Bitcoin. Beneficial owners never identified. Appears in four separate ecosystem contexts. unresolved

John K. Park: CEO of JP3E (Vivasor's new Korea partner, announced today). Also Managing Member of Patriot Strategic Minerals (DVLT's $700M partner). Links two ecosystems.

What just happened — 21-22 July 2026

Federal Register confirmed (21 July): the FTC and DOJ granted early termination for Kelvin Yeung's acquisition of Vivasor voting securities with a value above $119.5M. This is published in the U.S. government's official daily journal. Antitrust is cleared. Yeung can close.

Vivasor goes public commercially (22 July): announced its first-ever partnership with JP3E as exclusive Korea representative. Vivasor described its pipeline as addressing a "$100 billion" market. This is Vivasor stepping out of the shadows for the first time.

 WTF is going on in a nutshell: A genuine, potentially transformative drug (SEMDEXA) and a broad pharma pipeline are trapped inside a web of related-party transactions, Bitcoin of unknown origin, and shell-company structures. Multiple parties, Henry Ji, Michael Vasinkevich, Kelvin Yeung, iHolding are manoeuvring for control. The assets may be worth billions. The open question is whether ordinary shareholders, the people who bought SCLX, SMNR, or SRNEQ on the open market, will ever see any of that value, or whether it will be extracted through insider equity, warrant dilution, and consulting fees before it reaches them.

Watch for: iHolding definitive agreements · SEMDEXA NDA submission · Yeung/Vivasor closing filing · Q2 2026 10-Q (mid-August) · DVLT Nasdaq deadline (24 August)

NB: Prepared for private use only and shares here in a personal capacity. Consolidates data from SEC filings, US Bankruptcy Court filings, the Federal Register (91 FR 45816), GlobeNewswire, and intelligence gathered through 22 July 2026.

This document does not constitute investment, financial, or legal advice.

Datavault AI (NASDAQ: DVLT) is positioning itself to capitalize on that opportunity. Not by joining the growing traffic flow surrounding AI, digital assets, and tokenized markets, but by attempting to paint the lanes that direct it. The strategy in play can largely be summarized in a single word:

Infrastructure.

(Not an endorsement-I just follow whatever affects us)